Highlights
TSXV: ARCH       Arch Biopartners Inc
Last Price Today's Change   Day's Range   Trading Volume
0.98   0.00 (0.00%)  0.97 - 0.98  528

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.97 - 1.42
52 Weeks Price Volatility (%):
2.22%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company’s portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tract; MetaBlok which is a new drug candidate targeting sepsis, cancer metastasis and inflammation based diseases; Arch Inflammation which is a novel treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. It also develops Borg technology which is a solid surface interface to solid metal and plastic surfaces to inhibit biofilm formation and reduce corrosion; and MetaMx which is a synthetic molecule that targets brain tumor-initiating cells and invasive glioma cells.

  Be the first to like this.
 


 

890  748  1234  1712 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CVE 12.33+0.88 
 ECA 5.35+0.16 
 MFC 25.45+0.35 
 CNQ 38.91+2.00 
 HOD 3.975-0.095 
 CPG 4.80+0.19 
 BTE 1.50+0.05 
 SU 42.35+1.53 
 MRS 0.105+0.02 
 ARX 7.48+0.48 
Partners & Brokers